Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1953 1
1954 1
1955 1
1966 2
1969 1
1972 1
1974 1
1975 2
1977 1
1979 1
1980 3
1981 1
1983 1
1984 3
1985 2
1987 1
1990 1
1993 1
1994 1
1999 1
2000 3
2001 4
2002 2
2003 2
2005 1
2006 3
2007 1
2008 1
2009 4
2010 3
2011 1
2012 4
2013 10
2014 2
2015 5
2016 8
2017 7
2018 10
2019 7
2020 3
2021 10
2022 15
2023 13
2024 3

Text availability

Article attribute

Article type

Publication date

Search Results

130 results

Results by year

Filters applied: . Clear all
Page 1
Durvalumab Plus Carboplatin/Paclitaxel Followed by Maintenance Durvalumab With or Without Olaparib as First-Line Treatment for Advanced Endometrial Cancer: The Phase III DUO-E Trial.
Westin SN, Moore K, Chon HS, Lee JY, Thomes Pepin J, Sundborg M, Shai A, de la Garza J, Nishio S, Gold MA, Wang K, McIntyre K, Tillmanns TD, Blank SV, Liu JH, McCollum M, Contreras Mejia F, Nishikawa T, Pennington K, Novak Z, De Melo AC, Sehouli J, Klasa-Mazurkiewicz D, Papadimitriou C, Gil-Martin M, Brasiuniene B, Donnelly C, Del Rosario PM, Liu X, Van Nieuwenhuysen E; DUO-E Investigators. Westin SN, et al. J Clin Oncol. 2024 Jan 20;42(3):283-299. doi: 10.1200/JCO.23.02132. Epub 2023 Oct 21. J Clin Oncol. 2024. PMID: 37864337 Free PMC article. Clinical Trial.
Integrative Medicine for Ovarian Cancer.
Ben-Arye E, Lavie O, Heyl W, Ramondetta L, Berman T, Samuels N. Ben-Arye E, et al. Among authors: berman t. Curr Oncol Rep. 2023 Jun;25(6):559-568. doi: 10.1007/s11912-023-01359-8. Epub 2023 Mar 20. Curr Oncol Rep. 2023. PMID: 36939963 Review.
Benzophenone-3: Comprehensive review of the toxicological and human evidence with meta-analysis of human biomonitoring studies.
Mustieles V, Balogh RK, Axelstad M, Montazeri P, Márquez S, Vrijheid M, Draskau MK, Taxvig C, Peinado FM, Berman T, Frederiksen H, Fernández MF, Marie Vinggaard A, Andersson AM. Mustieles V, et al. Among authors: berman t. Environ Int. 2023 Mar;173:107739. doi: 10.1016/j.envint.2023.107739. Epub 2023 Jan 6. Environ Int. 2023. PMID: 36805158 Free article. Review.
Household medical waste disposal policy in Israel.
Barnett-Itzhaki Z, Berman T, Grotto I, Schwartzberg E. Barnett-Itzhaki Z, et al. Among authors: berman t. Isr J Health Policy Res. 2016 Oct 10;5:48. doi: 10.1186/s13584-016-0108-1. eCollection 2016. Isr J Health Policy Res. 2016. PMID: 27766144 Free PMC article. Review.
Peppermint-flavored lidocaine.
Berman TM. Berman TM. N Engl J Med. 1979 Aug 23;301(8):437. doi: 10.1056/NEJM197908233010818. N Engl J Med. 1979. PMID: 460352 No abstract available.
Harmonized human biomonitoring in European children, teenagers and adults: EU-wide exposure data of 11 chemical substance groups from the HBM4EU Aligned Studies (2014-2021).
Govarts E, Gilles L, Rodriguez Martin L, Santonen T, Apel P, Alvito P, Anastasi E, Andersen HR, Andersson AM, Andryskova L, Antignac JP, Appenzeller B, Barbone F, Barnett-Itzhaki Z, Barouki R, Berman T, Bil W, Borges T, Buekers J, Cañas-Portilla A, Covaci A, Csako Z, Den Hond E, Dvorakova D, Fabelova L, Fletcher T, Frederiksen H, Gabriel C, Ganzleben C, Göen T, Halldorsson TI, Haug LS, Horvat M, Huuskonen P, Imboden M, Jagodic Hudobivnik M, Janasik B, Janev Holcer N, Karakitsios S, Katsonouri A, Klanova J, Kokaraki V, Kold Jensen T, Koponen J, Laeremans M, Laguzzi F, Lange R, Lemke N, Lignell S, Lindroos AK, Lobo Vicente J, Luijten M, Makris KC, Mazej D, Melymuk L, Meslin M, Mol H, Montazeri P, Murawski A, Namorado S, Niemann L, Nübler S, Nunes B, Olafsdottir K, Palkovicova Murinova L, Papaioannou N, Pedraza-Diaz S, Piler P, Plichta V, Poteser M, Probst-Hensch N, Rambaud L, Rauscher-Gabernig E, Rausova K, Remy S, Riou M, Rosolen V, Rousselle C, Rüther M, Sarigiannis D, Silva MJ, Šlejkovec Z, Snoj Tratnik J, Stajnko A, Szigeti T, Tarazona JV, Thomsen C, Tkalec Ž, Tolonen H, Trnovec T, Uhl M, Van Nieuwenhuyse A, Vasco E, Verheyen VJ, Viegas S, Vinggaard AM, Vogel N, Vorkamp K… See abstract for full author list ➔ Govarts E, et al. Among authors: berman t. Int J Hyg Environ Health. 2023 Apr;249:114119. doi: 10.1016/j.ijheh.2023.114119. Epub 2023 Feb 9. Int J Hyg Environ Health. 2023. PMID: 36773580 Free article. Review.
U.S. FDA Drug Approvals for Breast Cancer: A Decade in Review.
Arora S, Narayan P, Osgood CL, Wedam S, Prowell TM, Gao JJ, Shah M, Krol D, Wahby S, Royce M, Ghosh S, Philip R, Ison G, Berman T, Brus C, Bloomquist EW, Fiero MH, Tang S, Pazdur R, Ibrahim A, Amiri-Kordestani L, Beaver JA. Arora S, et al. Among authors: berman t. Clin Cancer Res. 2022 Mar 15;28(6):1072-1086. doi: 10.1158/1078-0432.CCR-21-2600. Clin Cancer Res. 2022. PMID: 34711632 Free PMC article. Review.
130 results